Power Generalized KM-Transformation for Non-Monotone Failure Rate Distribution Authors
SCOPUA Journal of Applied Statistical Research · 2025
DOI: 10.64060/jasr.v1i3.1 ↗Kurz gefasst
Fachartikel in der Zeitschrift SCOPUA Journal of Applied Statistical Research, 2025. Verfasst von K S Deepthi und 1 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 22 Literaturangaben.
Abstract (Originalsprache)
A more useful transformation model, KM Transformation, for reliability and lifetime data analysis is introduced by Kavya & Manoharan (2021). Power generalization technique is the best approach for analysing a parallel system. In this article, we present a new transformation called Power Generalized KM-Transformation (PGKM) to obtain a more appropriate model while monotone and non-monotone behaviour for the failure rate function occurs. We derived the moments, moment generating function, characteristic function, quantiles, etc. for the PGKM transformation of Exponential distribution (PGKME). Distributions of minimum and maximum are obtained. Estimation of parameters of the PGKME distribution is performed via maximum likelihood method, method of moment, and least square estimation method. A simulation study is performed to validate the maximum likelihood estimator (MLE). Analysis of three sets of real data is provided.
Zitieren
APA
Deepthi, K. S., & Chacko, V. M. (2025). Power Generalized KM-Transformation for Non-Monotone Failure Rate Distribution Authors. SCOPUA Journal of Applied Statistical Research. https://doi.org/10.64060/jasr.v1i3.1
Vancouver
Deepthi KS, Chacko VM. Power Generalized KM-Transformation for Non-Monotone Failure Rate Distribution Authors. SCOPUA Journal of Applied Statistical Research. 2025. doi:10.64060/jasr.v1i3.1
BibTeX
@article{Deepthi2025,
author = {Deepthi, K S and Chacko, V M},
title = {Power Generalized KM-Transformation for Non-Monotone Failure Rate Distribution Authors},
journal = {SCOPUA Journal of Applied Statistical Research},
year = {2025},
doi = {10.64060/jasr.v1i3.1}
}
EUVIMED